DOBEK MARIA (Vice President, Accounting) sold 8.7% of their position (1.46K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $20.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/2/2026ACC: 0002032671-26-000002
Officer· Vice President, Accounting
Since Aug 2024
+60.07K
Net shares
Net buyer
$20.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
61.53K acquired · 1.46K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.46K
Price / share
$13.73
Trade value
$20.07K
% of position
8.7%
1/2/2026
16.84K→15.37K
Common Stock
Direct
Shares
+18.93K
Price / share
—
Trade value
—
% of position
123.2%
1/2/2026
15.37K→34.31K
Total
Net shares
+17.47K
Net value
-$20.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −1.46K | $13.73 | $20.07K | 8.7% | 16.84K | 15.37K |
| Common Stock Direct | 1/2/2026 | A · Award | +18.93K | — | — | 123.2% | 15.37K | 34.31K |
| Total | +17.47K | -$20.07K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
42.60K shares
Shares
+42.60K
Strike price
13.65
Held after
42.60K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock42.60K shares | 1/2/2026 | A · Award | +42.60K | 13.65 | — | 42.60K |